uksi/2016/867 — The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No.2) Regulations 2016

2016 No. 867 National Health Service, England The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No.2) Regulations 2016 Made 30th August 2016 Laid before Parliament 5th September 2016 Coming into force 1st October 2016 The Secretary of State for Health makes the following Regulations in exercise of the powers conferred by sections 6E(1) and (2) and 272(7) and (8) of the National Health Service Act 2006 . Citation and commencement 1 These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No.2) Regulations 2016 and come into force on 1st October 2016. Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 2 1 The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 are amended as follows. 2 In regulation 20 (interpretation)— a in the definition of “flat rate payment”, for “£112” substitute “£156.25”; b in the definition of “high band payment”, for “£154.14” substitute “£215.04”. Signed by authority of the Secretary of State. Prior Parliamentary Under-Secretary of State, Department of Health 30th August 2016 EXPLANATORY NOTE (This note is not part of the Regulations) These Regulations amend regulation 20 of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 ( S.I. 2012/2996 ). The amendments made by regulation 2(2) increase the rates for NHS-funded Nursing Care payable by the relevant body (the National Health Service Commissioning Board or a clinical commissioning group). A full impact assessment has not been produced for this instrument as no, or no significant impact on the private, voluntary or public sectors is foreseen.